Product Code: ETC052446 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The biologics market in Malaysia is expected to grow at a CAGR of 8.9% during the forecast period 2020-2026. The major factors driving the growth of the Malaysia biologics market include increasing patient awareness and knowledge about better therapeutic options, rising prevalence of chronic diseases such as cancer and diabetes, rising healthcare expenditure by public bodies, growing demand for advanced therapies like monoclonal antibodies, introduction of innovative technologies in drug manufacturing processes and increasing government initiatives towards improving access to treatment with high cost drugs
In addition to this, certain restraints such as lack of reimbursement policies leading to high costs for patients are expected to be experienced by this market over the next few years. However, companies operating in this space are continuously investing in R&D activities for development of biosimilars that can offer similar therapeutic effects at lower prices than those offered by branded counterparts; thus helping them gain an edge over their competitors. This trend is expected to support the expansion plans undertaken by various stakeholders present within this landscape over the coming years
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Biologics Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Biologics Market Revenues & Volume, 2020 & 2030F |
3.3 Malaysia Biologics Market - Industry Life Cycle |
3.4 Malaysia Biologics Market - Porter's Five Forces |
3.5 Malaysia Biologics Market Revenues & Volume Share, By Source, 2020 & 2030F |
3.6 Malaysia Biologics Market Revenues & Volume Share, By Product Type, 2020 & 2030F |
3.7 Malaysia Biologics Market Revenues & Volume Share, By Diseaseย Category, 2020 & 2030F |
3.8 Malaysia Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2020 & 2030F |
4 Malaysia Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Biologics Market Trends |
6 Malaysia Biologics Market, By Types |
6.1 Malaysia Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Biologics Market Revenues & Volume, By Source, 2020-2030F |
6.1.3 Malaysia Biologics Market Revenues & Volume, By Microbial, 2020-2030F |
6.1.4 Malaysia Biologics Market Revenues & Volume, By Mammalian, 2020-2030F |
6.1.5 Malaysia Biologics Market Revenues & Volume, By Others, 2020-2030F |
6.2 Malaysia Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2020-2030F |
6.2.3 Malaysia Biologics Market Revenues & Volume, By Vaccines, 2020-2030F |
6.2.4 Malaysia Biologics Market Revenues & Volume, By Recombinant Proteins, 2020-2030F |
6.2.5 Malaysia Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2020-2030F |
6.2.6 Malaysia Biologics Market Revenues & Volume, By Others, 2020-2030F |
6.3 Malaysia Biologics Market, By Diseaseย Category |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Biologics Market Revenues & Volume, By Oncology, 2020-2030F |
6.3.3 Malaysia Biologics Market Revenues & Volume, By Infectious Diseases, 2020-2030F |
6.3.4 Malaysia Biologics Market Revenues & Volume, By Immunological Disorders, 2020-2030F |
6.3.5 Malaysia Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2020-2030F |
6.3.6 Malaysia Biologics Market Revenues & Volume, By Hematological Disorders, 2020-2030F |
6.3.7 Malaysia Biologics Market Revenues & Volume, By Others, 2020-2030F |
6.4 Malaysia Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Biologics Market Revenues & Volume, By Outsourced, 2020-2030F |
6.4.3 Malaysia Biologics Market Revenues & Volume, By In-house, 2020-2030F |
7 Malaysia Biologics Market Import-Export Trade Statistics |
7.1 Malaysia Biologics Market Export to Major Countries |
7.2 Malaysia Biologics Market Imports from Major Countries |
8 Malaysia Biologics Market Key Performance Indicators |
9 Malaysia Biologics Market - Opportunity Assessment |
9.1 Malaysia Biologics Market Opportunity Assessment, By Source, 2020 & 2030F |
9.2 Malaysia Biologics Market Opportunity Assessment, By Product Type, 2020 & 2030F |
9.3 Malaysia Biologics Market Opportunity Assessment, By Diseaseย Category, 2020 & 2030F |
9.4 Malaysia Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2020 & 2030F |
10 Malaysia Biologics Market - Competitive Landscape |
10.1 Malaysia Biologics Market Revenue Share, By Companies, 2023 |
10.2 Malaysia Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |